Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer CellsSaloni Malla(University of Toledo), Amit K. Tiwari(University of Arkansas for Medical Sciences)CancersJuly 23, 202410.3390/cancers16152621Cited by 3SaveCiteExport RISWatch citationsRelated PapersA Novel Thienopyrimidine Analog, TPH104, Mediates Immunogenic Cell Death in Triple-Negative Breast Cancer Cells|Cancers|2021|20Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells|Cancers|2019|19Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis|Frontiers in Pharmacology|2018|18